Combined Liquid-Based Cytology and Conventional Smear Provides Better Sensitivity
and Adequacy Rates After Endoscopic Ultrasound-Guided Tissue Acquisition of Abdominal
Masses: A Systematic Review and Meta-Analysis
Background and Aims: Endoscopic ultrasound (EUS)-guided fine-needle aspiration (FNA)
or biopsy (FNB) is the standard method for diagnosing abdominal masses, but sample
inadequacy and diagnostic accuracy remain challenges. Conventional smear (CS) and
liquid-based cytology (LBC) are standard processing methods, yet their comparative
effectiveness and potential combined benefit remain unclear. We performed a systematic
review and meta-analysis to evaluate and compare the diagnostic performance and adequacy
of CS, LBC, and their combination. Methods: A systematic search was conducted in Medline,
Embase, and CENTRAL on 17 November 2024. Studies comparing CS, LBC, or their combination
following EUS-FNA/FNB for abdominal masses were included. Diagnostic parameters, including
sensitivity, specificity, accuracy, and inadequacy rates, were extracted and analyzed.
Methodological quality was assessed using QUADAS-2. Results: 16 studies (2128 patients)
were included. Sensitivity for pancreatic masses was 71.4% (CI: 62.9–78.7) for CS,
74.7% (CI: 64.3–82.8) for LBC, and 86.2% (CI: 82.4–89.3) for combined methods (p =
0.001). For all abdominal masses, sensitivity was 76.3% (CI: 67.9–83.0) for CS, 73.6%
(CI: 65.6–80.2) for LBC, and 88.0% (CI: 84.0–91.2) for combined methods (p ≤ 0.006).
Specificity was nearly 100%. Inadequacy rates were lowest for combined methods (1.5%,
CI: 0–36.2), when compared to LBC (7.7%, CI: 2.7–20.4) and CS (4.4%, CI: 2.4–7.9).
Moderate bias risk was noted, primarily due to incorporation bias. Domain 3 (reference
standard) of QUADAS was uniformly moderate-risk across studies. Conclusions: Combining
CS and LBC methods improves diagnostic sensitivity and reduces sample inadequacy after
EUS-guided tissue acquisition for abdominal masses, particularly pancreatic lesions.
Clinical guidelines should consider recommending the combined approach to enhance
diagnostic yield and clinical outcomes.